Irish Endocrine Society 34th Annual Meeting
Irish Endocrine Society 38th Annual Meeting
8th and 9th November 2013
The Hotel Kilkenny, Kilkenny
Local Organiser: Dr Colm McGurk, St Luke’s General Hospital, Kilkenny
Disclosure statement
This supplement is paid for by the Irish Endocrine Society. However the meeting costs are funded by the following commercial sponsors:
Abbott
Astra Zeneca
Boehringer Ingelheim
BMS
Eli Lilly
Ipsen
Menarini
MSD
Novartis
Novo Nordisk
Pfizer
Sanofi
Takeda
Novo Lecture Nordisk Lecture
|1976 |D.K.O’Donovan | |
|1977 |S. Bloom | |
|1978 |J.H.S. Robertson | |
|1979 |A.G. Cudworth | |
|1980 |D.A.D. Montgomery | |
|1981 |Peter Watkins | |
|1982 |G. Joplin | |
|1983 |D.R. London | |
|1984 |A.X. Bertagna | |
|1985 |Malcolm Nattrass |Laurence Kennedy |
|1986 |Brian Frier |JB Ferriss |
|1987 |Maurice Scanlon |TJ McKenna |
|1988 |D.A. Heath |AB Atkinson |
|1989 |J. Ward |GH Tomkin |
|1990 |R. Volpe |KD Buchanan |
|1991 |Michael Besser |PPA Smyth |
|1992 |R.V. Ragontte |DH Hadden |
|1993 |Bruce Weintraub |David Powell |
|1994 |Oscar Croffard |Patrick Bell |
|1995 |Robert Lindsay |Brian Sheridan |
|1996 |C.R.W. Edwards |Rosemary Freaney |
|1997 |Stephanie Amiel |David McCance |
|1998 |Robert Turner |Randle Hayes |
|1999 |Ian Hay |Sean K Cunningham |
|2000 |Stephen O'Rahilly |Michael Cullen |
|2001 |Andre Lacroix |Daphne Owens |
|2002 |J. Tuomilehto |Chris Thompson |
|2003 |Tony Weetman |John Nolan |
|2004 |R.V. Thakker |RGR Firth |
|2005 |P.M. Stewart |FMP O'Harte |
|2006 |Kevin Docherty |CH Walsh |
|2007 |Lynnette Nieman |Timothy O'Brien |
|2008 |Ken Ho |Donal O'Shea |
|2009 |Daniel J. Drucker |Steven Hunter |
|2010 |Joseph G. Verbalis |James Gibney |
|2011 |Thomas A. Buchanan |Maria Byrne |
|2012 |Beverly M.K. Biller |Fidelma Dunne |
Friday 8th November 2013
1pm to 1.45pm Poster Viewing session
1.50pm Welcome and introduction
Prof Tim O’Brien
President, Irish Endocrine Society
Friday Oral presentations
2.00pm OC1. Loss of the tumour suppressor micro-RNA 34a, and anti tumour cellular immunity in paediatric obesity – is obesity increasing the future risk of cancer in children?
Carolan E1, 2*, Hogan AE1, 2*, Corrigan M1, O’Connell J1, 3, Foley N4, O’Neill LA4, Cody D2 and O’Shea D1, 3
1Obesity Immunology Group, Education and Research Centre, St Vincent’s University Hospital, Dublin 4, 2Department of Endocrinology, Our Lady’s Children’s Hospital, Crumlin, Dublin 12, 3Department of Endocrinology, St Columcille’s Hospital, Loughlinstown, Dublin, 4Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2.
2.15pm OC2. Association between Type 2 Diabetes & inflammation
S Gupta2*, A Maratha1*, A Natarajan2, T Gajanayake1, J Siednienko1, S Hoashi2* and S Miggin1*
1Immune Signalling Laboratory, Institute of Immunology, National University of Ireland Maynooth, 2Midlands Regional Hospital, Mullingar, Co Westmeath, Ireland.
*joint authorship
2.30pm OC3. Endothelial cells induce osteoblastic activity in smooth muscle cells in a paracrine manner that is enhanced by receptor activator of nuclear factor kappa-beta ligand (RANKL)
Davenport C1, Martin FA2, Rochfort KD2, Murphy RP3, Cummins PM2, Smith D1
1 Department of Academic Endocrinology, Beaumont Hospital, Dublin, Ireland, 2School of Biotechnology, Dublin City University, Dublin, Ireland, 3School of Health & Human Performance, Dublin City University, Dublin, Ireland.
2.45pm OC4. Next Generation sequencing in Phaeochromocytoma and Paraganglioma: An Irish experience.
R.Casey*1, 3, A.Garrahy*1,P.O’Shea2, T.Higgins 3A.Tuthill4,D.O’Halloran4, C.Joyce5, M.Bell1
*=co first authors
1Department of Endocrinology ,2 Department of Clinical Biochemistry, Galway University Hospital, 3Department of Endocrinology,Tralee General Hospital,Tralee,Kerry, 4Department of Endocrinology, 5Department of Biochemistry, Cork University Hospital.
3.00pm OC5. Effect of cortisol dynamics on bone turnover in ACTH deficient hypopituitary patients receiving physiological hydrocortisone replacement.
Behan LA1, Kelleher G2, Hannon MJ1, Brady JJ3, Rogers B1, Tormey W2, Smith D1, Thompson CJ1, McKenna MJ4, Agha A1.
1Department of Endocrinology and Diabetes Metabolism, Beaumont Hospital, Dublin., 2Department of Chemical Pathology, Beaumont Hospital, Dublin., 3Metabolism Laboratory, St Vincent’s University Hospital, Dublin, 4Department of Endocrinology, St Vincent’s University Hospital, Dublin.
3.15pm OC6. Tissue-Specific Changes in Glucocorticoid Metabolism Following Bariatric Surgery
C. Woods1, M Corrigan1, LL Gathercole2, SA Morgan2, A. Taylor2, AE Hogan1, G. Goatswe1, PM Stewart2, J. Tomlinson2, D. O’Shea1 & M Sherlock 2,3.
Education & Research Centre, St Vincent’s University Hospital & St Columcille’s Hospital1 .Centre for Endocrinology, Diabetes & Metabolism, Institute of Biomedical Research, University of Birmingham2. Department of Endocrinology, Tallaght Hospital, Dublin
3.30-4.25pm Coffee and Poster display
4.30pm OC7. Oligo-amenorrhoea, infertility and low oocyte yield during fertility treatment secondary to a novel luteinizing hormone receptor mutation; a case series.
Behan LA, Mitri F, Weintraub A, Esfandiari N, Chang P, Bentov Y and Casper RF
Toronto Centre for Advanced Reproductive Technology, Division of Reproductive Sciences, Department of Obstetrics and Gynaecology, University of Toronto and Samuel Lunenfeld Research Institute.
4.45pm OC8. Effects of Normalising Testosterone and Oestradiol Levels on Cardiovascular and Bone Health in Men with Severe Obesity: A Randomised Clinical Trial
Ahern T1-3, Khattak A1-3, Reece R4, Kilbane MT5, Smith T6, Ryan T1, Lehane C2, O’Keane M5, McKenna MJ3,5, O’Shea D1-3, Hayes FJ3.
1 Department of Endocrinology, St Columcille’s Hospital, Loughlinstown, Co Dublin
2 Obesity Research Group, Education and Research Centre, St Vincent’s University Hospital, Elm Park, Dublin 4, 3Department of Endocrinology, St Vincent’s University Hospital, Elm Park, Dublin 4 , 4 Biochemistry Laboratory, St Vincent’s University Hospital, Elm Park, Dublin 4 ,5 Metabolism Laboratory, St Vincent’s University Hospital, Elm Park, Dublin 4., 6 Endocrinology Laboratory, St Vincent’s University Hospital, Elm Park, Dublin 4.
5.00 pm 38th Annual Novo Lecture
"Seeking diamonds in the dirt: biological insights and translational opportunities from type 2 diabetes genetic analyses"
Prof Mark McCarthy MB BCHir, MD, FRCP, FSB, FMedSci
Robert Turner Professor of Diabetes,
University of Oxford
Oxford Centre for Diabetes, Endocrinology and Metabolism
Churchill Hospital,
Old Road, Headington, Oxford
and
Wellcome Trust Centre for Human Genetics,
University of Oxford,
Roosevelt Drive, Oxford.
Saturday 9th November 2013
8.30 – 9.25 am Annual General Meeting
Saturday Oral presentations
9.30 am OC9. Intestinal cholesterol-metabolism gene expression is associated with abnormalities in post-prandial endothelial function and carotid intima-media thickness.
Widdowson WM1, McGowan A1, Phelan J3, Boran G2, Reynolds J3, and Gibney J1.
Departments of Endocrinology and Diabetes Mellitus1, and Chemical Pathology2, Tallaght Hospital, Dublin 24, Department of Surgery3, St James’s Hospital, Dublin 8.
9.45 am OC10. Clinical profile of patients with type 1 diabetes at Galway University Hospital
T.G. Cotter, S Dinneen, M Bell, F Dunne, F Finucane, M Gately, T O’Brien
Department of Endocrinology, Galway University Hospital, Galway
10.00 am OC11. ATLANTIC DIP: Excessive gestational weight gain and pregnancy outcomes in women with gestational or pre-gestational diabetes mellitus.
Egan AM, Dennedy MC, Al-Ramli W, Heerey A, Avalos G, Dunne F.
Galway Diabetes Research Centre, National University of Ireland, Galway.
10.15 am OC12. Both protein and fat increase postprandial glucose excursions in children with type 1 diabetes and the effect is additive
SM O’Connell1,2, CE Smart3, M Evans2, P McElduff3, PE Lopez3,TW Jones2, EA Davis2, BR King3
1Department of Paediatrics, Cork University Hospital, Cork, Ireland
2Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, and Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia
3University of Newcastle, School of Medicine, Faculty of Health, and John Hunter Children's Hospital, Department of Paediatric Endocrinology, Newcastle, Australia
10.30 am 26th Annual Nordisk Lecture
‘Osteoprotegerin- a common pathway between the bone and vasculature
In diabetes?’
Dr Diarmuid Smith MB MD FRCPI
Consultant in Diabetes and Endocrinology
Beaumont Hospital
Dublin
11.00-11.30 am Coffee/poster presentation session
11.30 am OC13. The prognostic significance of hypoglycaemia on oral glucose tolerance tests in adults with cystic fibrosis (CF): a prospective cohort study.
KJ Neff1, 2*, MJ Harrison1,3*, C Fleming1, M McCarthy1, C Shortt1, SM O’Riordan4, DM Murphy1, BJ Plant1,3. DJ O’Halloran2,
Department of Endocrinology and Metabolism, Cork University Hospital1
Cystic Fibrosis Centre, Department of Respiratory Medicine, Cork University Hospital2
HRB Clinical Research Facility, University College Cork3
Department of Paediatrics, Cork University Hospital4
*authors contributed equally
11.45 am OC14. Postprandial studies uncover differing effects on HDL particles of overt and subclinical hypothyroidism
McGowan A1, Widdowson WM1, O’Regan A3, Young I3, Boran G2, McEneny J3, Gibney J1
Departments of Endocrinology1 and Chemical Pathology2, Tallaght Hospital, Dublin 24
Centre for Public Health, Queen’s University Belfast, Northern Ireland3
12.00 am OC15. GPR119 expression in islets and the effects of GPR119 agonists on insulin secretion in-vitro and in-vivo
B. M. Moran, Y. H. A. Abdel-Wahab, P. R. Flatt, A. M. McKillop
Biomedical Sciences Research Institute, SAAD Centre for Pharmacy & Diabetes, University of Ulster, Cromore Road, Coleraine, BT52 1SA, Northern Ireland.
12.15 pm OC16. Interleukin 17 is elevated in obesity and diabetes, and reduced by treatment with a glucagon-like peptide 1 analogue.
Gaoatswe G, Woods C, Corrigan MA, Hogan AE, O’Shea D
Department of Endocrinology, St Vincent’s University Hospital & St Columcille’s Hospital, Dublin.
12.30 pm OC 17. Elevated 12-HETE levels at type 1 diabetes onset but not in established disease.
E. Hennessy1, A. Rakovac Tisdall2, N. Murphy3, A. Carroll3, D. O’Gorman4, L. Breen1,4, C. Clarke1, M. Clynes1, P. Dowling1, S. Sreenan2.
1National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9,
2Connolly Hospital Blanchardstown, Dublin 15, 3Children’s University Hospital, Temple Street, Dublin 1, 4Centre for Preventative Medicine, School of Health and Human Performance, Dublin City University, Glasnevin, Dublin 9.
12.45 pm OC18. Dogfish glucagon and (D-Ala2)dogfish glucagon show novel glucose lowering and insulinotropic actions mediated by incretin receptors in mice
FPM. O'Harte, AM Lynch, PR Flatt
School of Biomedical Sciences, University of Ulster, Coleraine, N. Ireland.
13.00 pm Presentation of Irish Endocrine Society O’Donovan Medal (best oral presentation) and Montgomery Medal (best poster presentation).
Close of meeting
ABSTRACTS
Oral Presentations
OC1. Loss of the tumour suppressor micro-RNA 34a, and anti tumour cellular immunity in paediatric obesity – is obesity increasing the future risk of cancer in children?
Carolan E1, 2*, Hogan AE1, 2*, Corrigan M1, O’Connell J1, 3, Foley N4, O’Neill LA4, Cody D2 and O’Shea D1, 3
1Obesity Immunology Group, Education and Research Centre, St Vincent’s University Hospital, Dublin 4, 2Department of Endocrinology, Our Lady’s Children’s Hospital, Crumlin, Dublin 12, 3Department of Endocrinology, St Columcille’s Hospital, Loughlinstown, Dublin, 4Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2.
There is strong epidemiological data linking obesity to an increased risk of various cancers. Whether childhood obesity is an independent risk factor for future malignancy is not fully established. We hypothesized that childhood obesity is associated with altered key immune anti-tumour mechanisms.
Peripheral blood mononuclear cells were isolated from 61 patients aged 6-18yrs. The expression of microRNA 34a (miR34a), a target for tumour suppressor gene p53 was quantitatively measured. Cytotoxicity assays determining natural killer (NK) cell activity and immunophenotyping were performed.
The age and BMI Z-score of obese participants were 12.9±3.0years and 3.3±0.4 respectively and non-obese participants were 12.2±2.9years and 0.4±0.9.
|Parameter |Obese |Non-Obese |P Value |
| |(n=40) |(n=21) | |
|CD8 Cytotoxic T cells |25.3±7.1 |30.3±6.6 |0.03 |
|(%CD3+T cells) | | | |
|Invariant Natural Killer T cell (%CD3+T |0.32±0.03 |0.54±0.02 | ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- levophed norepinephrine bitartrate injection usp rx
- vasoactive medications aacn
- sjh sje critical care intravenous medications
- vasopressor and inotrope usage in shock
- standardised inotrope and vasopressor guidelines
- vasoactive continuous infusions adult inpatient
- delegation protocol number delegation protocol
- vasoactive drip titration chart home emergency medicine
- jones bartlett learning
- diagnostic radiology ultrasound and vascular ultrasound
Related searches
- eb annual meeting 2019
- eb annual meeting 2020
- bio annual meeting 2020
- annual meeting theme ideas
- company annual meeting themes
- child neurology society annual meeting 2020
- society for neuroscience meeting 2019
- aann annual meeting 2020
- asco 2020 annual meeting registration
- asco annual meeting 2020 agenda
- asco 2019 annual meeting agenda
- asco annual meeting registration